Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4474
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acorda Therapeutics (Acorda or ‘the company’) is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Acorda Therapeutics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Acorda Therapeutics, Inc.: Company Overview 9
Acorda Therapeutics, Inc.: Overview and Key Facts 9
Acorda Therapeutics, Inc.: Overview 9
Acorda Therapeutics, Inc.: Key Facts 9
Acorda Therapeutics, Inc.: Key Employees 11
Acorda Therapeutics, Inc.: Key Employee Biographies 12
Acorda Therapeutics, Inc.: Major Products and Services 19
Acorda Therapeutics, Inc.: Company History 20
Acorda Therapeutics, Inc.: Management Statement 23
Acorda Therapeutics, Inc.: Locations and Subsidiaries 25
Acorda Therapeutics, Inc.: Key Competitors 26
Acorda Therapeutics, Inc.: Company Analysis 27
Acorda Therapeutics, Inc.: Business Description 27
Acorda Therapeutics, Inc.: SWOT Analysis 28
Acorda Therapeutics, Inc.: SWOT Overview 28
Acorda Therapeutics, Inc.: Strengths 28
Acorda Therapeutics, Inc.: Weaknesses 29
Acorda Therapeutics, Inc.: Opportunities 29
Acorda Therapeutics, Inc.: Threats 30
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity 32
Acorda Therapeutics, Inc.: Financial Deals Overview 32
Acorda Therapeutics, Inc.: Targets and Partners 34
Acorda Therapeutics, Inc.: Top Deals 2014 – 2018YTD* 35
Acorda Therapeutics, Inc.: Advisors 36
Acorda Therapeutics, Inc.: Top Legal Advisors 36
Acorda Therapeutics, Inc.: Top Financial Advisors 36
Acorda Therapeutics, Inc.: Mergers and Acquisitions 37
Acorda Therapeutics, Inc.: Private Equity and Ownership 38
Acorda Therapeutics, Inc.: Recent Developments 39
Acorda Therapeutics, Inc.: News and Events Summary 39
Acorda Therapeutics, Inc.: Corporate Governance 42
Acorda Therapeutics, Inc.: Financial Performance 42
Acorda Therapeutics, Inc.: Market Developments 43
Acorda Therapeutics, Inc.: Red Flags/DistressSignals 44
Acorda Therapeutics, Inc.: Research & Development 44
Acorda Therapeutics, Inc.: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Locations and Subsidiaries
Table 4: Acorda Therapeutics, Inc.: Key Competitors
Table 5: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 16: Acorda Therapeutics, Inc.: News and Events Summary
Table 17: Acorda Therapeutics, Inc.: Corporate Governance
Table 18: Acorda Therapeutics, Inc.: Financial Performance
Table 19: Acorda Therapeutics, Inc.: Market Developments
Table 20: Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Table 21: Acorda Therapeutics, Inc.: Research & Development
Table 22: Acorda Therapeutics, Inc.: Strategy and Operations

List of Figures
Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Acorda Therapeutics, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • El Puerto de Liverpool SAB de CV:企業の戦略・SWOT・財務情報
    El Puerto de Liverpool SAB de CV - Strategy, SWOT and Corporate Finance Report Summary El Puerto de Liverpool SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Orano SA:電力:M&Aディール及び事業提携情報
    Summary Orano SA (Orano), formerly New AREVA Holding, is an integrated nuclear energy company that transforms nuclear materials and provides technological solutions for power generation and allied services. It offers complete range of products and services that covers the entire nuclear fuel cycle r …
  • PaR Systems LLC:企業の戦略的SWOT分析
    PaR Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Phillips 66 Co (PSX):石油・ガス:M&Aディール及び事業提携情報
    Summary Phillips 66 Co (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports, stores and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants. It also transports, fractionates and markets natural gas …
  • Valaris Plc (VAL):企業の財務・戦略的SWOT分析
    Valaris Plc (VAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UMW Holdings Bhd (UMW):企業の財務・戦略的SWOT分析
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Givaudan SA:戦略・SWOT・企業財務分析
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Orlen Upstream Sp zoo:石油・ガス:M&Aディール及び事業提携情報
    Summary Orlen Upstream Sp zoo (Orlen Upstream), a subsidiary of Polski Koncern Naftowy Orlen SA is an oil and gas company that offers petroleum products and natural gas. The company provides products such as motor fuel, diesel, LPG, marine fuel, aviation fuel, greases, kerosene, brake fluids, techni …
  • Windtree Therapeutics Inc (WINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • Tokyo Printing Ink Mfg Co Ltd (4635):企業の財務・戦略的SWOT分析
    Tokyo Printing Ink Mfg Co Ltd (4635) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • KKR & Co. L.P.:企業の戦略・SWOT・財務情報
    KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nachi-Fujikoshi Corp (6474):企業の財務・戦略的SWOT分析
    Nachi-Fujikoshi Corp (6474) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ecobank Transnational Inc:企業の戦略・SWOT・財務情報
    Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report Summary Ecobank Transnational Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kartonsan Karton Sanayi ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Kartonsan Karton Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Xerium Technologies Inc:企業の戦略的SWOT分析
    Xerium Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆